Determining Vaccination Frequency in Farmed Rainbow Trout Using Vibrio anguillarum O1 Specific Serum Antibody Measurements by Holten-Andersen, Lars et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Determining Vaccination Frequency in Farmed Rainbow Trout Using Vibrio
anguillarum O1 Specific Serum Antibody Measurements
Holten-Andersen, Lars; Dalsgaard, Inger; Nylén, Jørgen; Lorenzen, Niels; Buchmann, Kurt
Published in:
P L o S One
Link to article, DOI:
10.1371/journal.pone.0049672
Publication date:
2012
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Holten-Andersen, L., Dalsgaard, I., Nylén, J., Lorenzen, N., & Buchmann, K. (2012). Determining Vaccination
Frequency in Farmed Rainbow Trout Using Vibrio anguillarum O1 Specific Serum Antibody Measurements. P L
o S One, 7(11), e49672. DOI: 10.1371/journal.pone.0049672
Determining Vaccination Frequency in Farmed Rainbow
Trout Using Vibrio anguillarum O1 Specific Serum
Antibody Measurements
Lars Holten-Andersen1,2*, Inger Dalsgaard2, Jørgen Nyle´n3, Niels Lorenzen4, Kurt Buchmann1
1Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark, 2Division of Veterinary
Diagnostics and Research, National Veterinary Institute, Technical University of Denmark, Copenhagen, Denmark, 3Aqua Denmark Unit, MSD Animal Health, Ballerup,
Denmark, 4Division of Poultry, Fish and Fur Animals, National Veterinary Institute, Technical University of Denmark, Aarhus N, Denmark
Abstract
Background: Despite vaccination with a commercial vaccine with a documented protective effect against Vibrio anguillarum
O1 disease outbreaks caused by this bacterium have been registered among rainbow trout at Danish fish farms. The present
study examined specific serum antibody levels as a valid marker for assessing vaccination status in a fish population. For this
purpose a highly sensitive enzyme-linked immunosorbent assay (ELISA) was developed and used to evaluate sera from
farmed rainbow trout vaccinated against V. anguillarum O1.
Study Design: Immune sera from rainbow trout immunised with an experimental vaccine based on inactivated V.
anguillarum O1 bacterin in Freund’s incomplete adjuvant were used for ELISA optimisation. Subsequently, sera from farmed
rainbow trout vaccinated with a commercial vaccine against V. anguillarum were analysed with the ELISA. The measured
serum antibody levels were compared with the vaccine status of the fish (vaccinated/unvaccinated) as evaluated through
visual examination.
Results: Repeated immunisation with the experimental vaccine lead to increasing levels of specific serum antibodies in the
vaccinated rainbow trout. The farmed rainbow trout responded with high antibody levels to a single injection with the
commercial vaccine. However, the diversity in responses was more pronounced in the farmed fish. Primary visual
examinations for vaccine status in rainbow trout from the commercial farm revealed a large pool of unvaccinated specimens
(vaccination failure rate = 20%) among the otherwise vaccinated fish. Through serum analyses using the ELISA in a blinded
set-up it was possible to separate samples collected from the farmed rainbow trout into vaccinated and unvaccinated fish.
Conclusions: Much attention has been devoted to development of new and more effective vaccines. Here we present a
case from a Danish rainbow trout farm indicating that attention should also be directed to the vaccination procedure in
order to secure high vaccination frequencies necessary for optimal protection with a reported effective vaccine.
Citation: Holten-Andersen L, Dalsgaard I, Nyle´n J, Lorenzen N, Buchmann K (2012) Determining Vaccination Frequency in Farmed Rainbow Trout Using Vibrio
anguillarum O1 Specific Serum Antibody Measurements. PLoS ONE 7(11): e49672. doi:10.1371/journal.pone.0049672
Editor: Pierre Boudinot, INRA, France
Received May 25, 2012; Accepted October 11, 2012; Published November 21, 2012
Copyright:  2012 Holten-Andersen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the Danish Agency for Science, Technology and Innovation (MarinVac, DSF jnr 09-063102). The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: JN is an employee of MSD Animal Health. The commercial vaccine used in this project was provided by MSD Animal Health. This does not
alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: lhoa@life.ku.dk
Introduction
Salmonid aquaculture has increased three-fold since 1980 and
aquaculture in general is by far the fastest growing sector of food
animal production in the world. In Denmark, where the focus is
on rainbow trout, the production is equally expected to grow over
the next few years. However, it is also expected that the increase in
production should not lead to a corresponding growth in
consumption of antimicrobials. Hence, the use of commercial
vaccines against bacterial infections has spread and vaccination is
now taking place at all farms with marine net cages as part of the
production line. The commercial vaccine used in Denmark for
injection vaccination is an oil-adjuvanted construct containing
whole-cell antigen preparations of Aeromonas salmonicida subsp.
salmonicida and Vibrio anguillarum serovar O1 and O2. However,
despite the use of such vaccines infections with V. anguillarum might
occur at the farms. This marine bacterium is found regularly on
marine rainbow trout farms in Denmark and can be a significant
cause of mortality in the stocked fish [1,2]. While the level of
protection from the vaccines may vary against A. salmonicida subsp.
salmonicida, the vaccine efficacy against V. anguillarum is generally
high [3]. Hence, we speculated that part of the explanation for the
infections with V. anguillarum might be found in the vaccination
procedure. To answer this question, we developed a highly
sensitive and specific ELISA as a tool for monitoring vaccination
frequencies in rainbow trout populations following large-scale
vaccination procedures. With this assay we determined levels of
anti-V. anguillarum antibodies in sera from farmed trout and
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compared these findings with visual examinations of the fish based
on the Speilberg scale [4].
Results
Assay Characteristics
Coating antigen. Coating the microplates with sonicated
bacteria compared with whole-cell antigen coating led to
significantly different OD readings with serum (pooled, n= 20)
from unvaccinated fish (control) diluted 1:1000 (P,0.0001),
1:5000 (P = 0.003) and 1:10000 (P = 0.009) in assay buffer. OD
values for unvaccinated fish were lowest in microplates coated with
sonicated material (Fig. 1). The two coatings also produced
significantly different readouts with serum (pooled, n = 20) from
three times immunised rainbow trout (formalin-killed V. anguillarum
O1 in FIA) diluted 1:1000 (P= 0.012), 1:5000 (P= 0.0004) and
1:10000 (P = 0.0002). However, in the vaccinated fish the highest
OD values were measured in microplates coated with sonicated
bacteria. When antigen (V. anguillarum sonicate) was omitted from
the coating buffer, reactions were not significantly different from
blank wells (sample dilution buffer only; data not shown).
Dilution series and analytical signal. Representative
titration curves based on pooled sera from unvaccinated rainbow
trout and sera pooled from fish immunised one, two or three times
are shown in Fig. 2. The plotted data produced sigmoid curves for
the immunised fish, whereas serum from the naı¨ve fish generated a
linear horizontal curve showing a slight increase in background at
the highest serum concentrations. The absorbance at 450 nm
against the serum dilution factor exhibited a linear relationship in
a narrow dilution range for all three immune sera with slopes
increasing with the number of immunisations. The limit of
detection for the V. anguillarum O1 assay was an OD of 0.066.
Intra- and interassay precision. The analysis of eight
determinations of the same serum sample on one microplate gave
a CV#3.4% at 1:1000 and 1:5000 dilutions. The interassay CV
was #6.3% based on duplicates of both dilutions of the control
serum pool on individual plates run on 14 different days.
Stability The level of specific antibodies in the serum samples
remained unchanged through ten cycles of freeze/thaw. In
addition, keeping samples at room temperature for 24 h had no
effect on antibody levels (data not shown).
Antibody Titre Increase for Each Immunisation
Sera from the fish that received three consecutive immunisa-
tions i.p. with a test vaccine were analysed individually for vaccine
specific antibodies and Fig. 3 displays these data presented as OD
values. As shown, there was no significant difference between
control fish (0.1060.0) and rainbow trout immunised once
(0.2460.14). However, following both the second (1.060.19)
and third immunisation (2.6460.23) a significant increase in V.
anguillarum O1 specific antibodies was observed. Highest OD
Figure 1. Performance of two different ELISAs coated with
either whole cell or sonicated bacterial antigen. Serum pools
from 20 unvaccinated (PBS injected, control) and 20 vaccinated (three
immunisations) were analysed in 1:1000, 1:5000, and 1:10000 dilutions.
doi:10.1371/journal.pone.0049672.g001
Figure 2. Titration curves based on pooled sera from 20
controls and 20 rainbow trout immunised i.p. one, two or three
times with an experimental vaccine (formalin-killed V. angu-
illarum O1 in FIA).
doi:10.1371/journal.pone.0049672.g002
Figure 3. Antibody responses to repeated immunisations
followed in 20 rainbow trout. Serum samples from 20 controls
and 20 rainbow trout immunised i.p. one, two or three times with an
experimental vaccine were analysed individually. All samples were
diluted 1:1000.
doi:10.1371/journal.pone.0049672.g003
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values were found with serum from rainbow trout immunised
three times.
Frequency of Unvaccinated Fish in a Population of
Farmed Rainbow Trout
For a final evaluation of the V. anguillarum ELISA as a tool for
determining vaccine status in farmed rainbow trout populations,
blood samples were collected from 50 fish at a Danish sea farm.
The fish were also examined for visual signs of previous
vaccination. 15 months prior to this sampling 50 fish from the
same batch of rainbow trout were randomly collected from the
pond of supposedly vaccinated fish on the day of vaccination and
visually examined for their vaccine status. The data from the visual
examinations are presented in Table 1. There were found ten
apparently unvaccinated fish (20%) out of the 50 examined
specimens at both the fresh water and salt-water facility. This
frequency of unvaccinated fish was confirmed with the ELISA
(Fig. 4). OD values were significantly associated with the status as
unvaccinated (P,0.0001) with an AUC of 1.00 (95% CI: 1.00–
1.00). Moreover, the receiver operating characteristic (ROC)
analysis showed 100% specificity and 100% sensitivity for the
ELISA with an OD value cut-off set at 0.973. Based on these
observations the 50 fish from the salt-water facility were divided
into an unvaccinated and vaccinated group, and their data on size
and condition are presented in Table 2. Although the unvacci-
nated fish were slightly longer compared to the vaccinated group
(P = 0.041), the weight (P = 0.12) and average condition factor
(P = 0.12) of the two groups were not significantly different.
Discussion
Rainbow trout in culture suffer a variety of diseases, including
bacterial, viral, parasitic and fungal infections. The majority of
infections described are bacterial; including vibriosis caused by the
extracellular bacterium V. anguillarum. Modern aquaculture takes
prophylactic measures such as vaccination to combat serious
infections, and with the continuous expansion of this industry
there is an ongoing development of more effective ways to deliver
vaccines to the fish [5]. In recent years refined machines for i.p.
injections in fish have made automated vaccination a true
alternative to manual vaccine delivery. However, the larger
number of vaccinated fish per hour comes with an increased risk of
vaccination failure if these machines are not handled optimally
(personal observation). In Norway, being one of the largest
producers of salmonids in aquaculture, the accepted vaccination
failure rate at their fish farms is #2%. In Danish rainbow trout
farming such a failure rate has yet to be agreed on.
The present study focused on the development and validation of
an indirect ELISA for measuring anti-V. anguillarum O1 antibody
levels as a marker for positive vaccination. The final assay was
evaluated for its potential to determine the vaccination rate in a
smaller population of rainbow trout subjected to automated
vaccination against vibriosis at a Danish trout farm. Hence, the
goal was to investigate and develop an assay useful for the farmers
in determining the frequency of fish that accidentally have not
received the vaccine after large-scale vaccination.
The development of a sensitive and specific ELISA requires
special attention to a number of steps involved in the assay, here
among the coating of the microplates. It has been described how
optimising the coating process can lead to significantly better
performance of the ELISA when the coating antigen is complex
material like whole cell suspensions [6]. In our study, sonicated V.
anguillarum O1 was found superior to whole cell V. anguillarum O1
as coating antigen in terms of significantly increased specific signal
and lowered background. The reason for the better assay
performance with sonicated coating material might simply be a
larger number of exposed antigens on the bottom of the wells.
Nonetheless, the result is a highly sensitive and specific ELISA,
which is essential if the assay is to be used in screening for
vaccination frequencies.
In the present study an experimental vaccine based on FIA and
one inactivated bacterial isolate induced a weaker antibody
response in rainbow trout compared to a commercial vaccine
holding three bacterial isolates. However, the results were not
directly comparable since fish stocks and rearing conditions
differed. Moreover, there was a 15-month period between
vaccination and serum sampling in case of the field-reared fish
compared to 4K months for the experimental fish. Nonetheless,
the explanation for the observed difference could by a higher
potency in multivalent vaccines [7]. Such an effect could possibly
in part be attributed to a larger amount of bacterial immuno-
modulators in multivalent vaccines. Indeed, many of the most
promising experimental adjuvant components are bacterially
derived molecules that have been identified as highly conserved
ligands for a range of immunologically important receptors on
antigen presenting cells [8,9]. Finally, it may not be excluded that
cross-reactive antibodies targeted at such conserved and thus
shared epitopes between V. anguillarum and A. salmonicida have been
induced by the A. salmonicida component in the commercial
vaccine.
High levels of anti-V. anguillarum O1 antibodies were measured
with this ELISA in sera from sea-farmed rainbow trout. In
agreement with a previous report our analyses revealed a large
variation in specific antibody levels among truly vaccinated fish
[10]. Since it was outside the scope of this study to investigate
protective qualities of the antibodies measured with the described
ELISA it is unresolved whether these differences in titres reflect
different levels of protection against vibriosis. However, such
specific antibodies have been shown to confer protection in
rainbow trout against vibriosis [7,11,12]. Moreover, it has been
suggested that the protective immune response in rainbow trout
against extracellular bacteria, like in higher vertebrates, is
predominantly humoral [13]. Hence, we speculate that high
numbers of unvaccinated fish with a very low antibody response
against V. anguillarum O1 as reported here could be part of the
explanation for the vibriosis outbreaks observed at Danish sea
farms [2]. However, further studies including larger populations of
Figure 4. A scatter dot plot showing specific serum antibody
responses from 50 farmed rainbow trout vaccinated once with
a commercial vaccine against V. anguillarum. The dotted line
represents the cut-off value for the ELISA at 0.97. All samples were
diluted 1:1000.
doi:10.1371/journal.pone.0049672.g004
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fish sampled at several farms are needed for conclusions on this
theory.
There was not registered any outbreaks of vibriosis in the
rainbow trout population during the study period. This might
explain that the frequency of unvaccinated fish in the population
had not decreased over time between the two sampling points.
However, these outbreaks normally occur at the sea farms during
summer when water temperatures are highest and hence would be
expected to arise after the final sampling time point in the present
study [1,2]. Thus, it remains to be investigated how the presence
and frequency of unvaccinated fish affects the risk and seriousness
of an outbreak of vibriosis among the farmed fish. Possibly, herd
immunity could be provided to a certain level by the 80%
vaccinated fish. In terms of analysis of the antibody response in sea
reared rainbow trout it also should be determined how an
infection with V. anguillarum affects the antibody profiles of the fish.
However, this will not hamper the usability of the ELISA for
screening purposes since the testing of vaccination status normally
will be performed before the fish are transferred to environments,
e.g. sea cages, potentially infected with V. anguillarum O1. Indeed,
the ELISA revealed that apparently unvaccinated fish, although
low, still had an antibody response against V. anguillarum O1, which
might be the result of natural exposure to environmental V.
anguillarum after transfer to the sea cages. Optimally, an
unvaccinated control group should have been included in the
field study for interpretation of potential exposure to environmen-
tal V. anguillarum. However, this was not feasible since all fish
intended for sea cage rearing in Denmark should be vaccinated. A
maximum water temperature of 15uC monitored at the sea farm
during the test period would explain the lack of disease outbreak
despite potential bacterial exposure. Distinguishing between non-
specific reactivity and low level specific reactivity is a key problem
in the development of ELISA [14,15]. To reduce the probability of
false positive results (e.g. fish with detectable antibody levels
induced by environmental bacterial exposure) it might be
necessary, as in the present study, to set a relatively high cut-off
value for the assay. However, this will also increase the probability
of false negative results [10].
Apart from monitoring and improving efficacy of the vaccina-
tion procedure, knowledge on the immunological status of the
actual fish population provided by the ELISA would help the
farmer to handle vibriosis outbreaks in a more rational manner. As
with other severe diseases vibriosis can lead to reduced net growth,
increased need for treatment, and loss of fish dying from infection
[16]. Thus, the ELISA presented here could be a useful tool for the
fish farmer, and compared to visual examination it has the
advantage that no fish needs to be killed in the process (sampling
can be done on-site and the fish released).
Materials and Methods
Ethics Statement
The Committee for Animal Experimentation, Ministry of
Justice, Copenhagen, Denmark, approved the study including
the fish rearing and experimentation (license number 2006/561-
1204), which was performed following the ethical guidelines listed
in the license. All animal procedures were in agreement with the
EU Directive 2010/63/EU for animal experiments?
Fish and Rearing Conditions
Rainbow trout (Skinderup strain, Jutland, Denmark) were
hatched and reared under pathogen-free conditions (Danish
Centre for Wild Salmon, Randers, Denmark), before they were
brought to our experimental fish keeping facility. The pathogen-
free status of the fish was confirmed in the laboratory. 40 rainbow
trout (average weight 25 g/fish) were split into two groups of 20
fish each. The fish were kept in 200 L tanks (20 fish/tank) with bio-
filters (Eheim, Germany) and maintained at a 12 h light and 12 h
dark cycle in aerated (100% oxygen saturation) tap water at 12uC.
One group was injected once intraperitoneally (i.p.) with PBS
(control) while the other group received three consecutive
immunisations i.p. with an experimental vaccine.
A commercial aquaculture production line considered repre-
sentative for Danish rainbow trout farming comprising both fresh
water and salt-water facilities was selected for the field sampling.
The rainbow trout population for this production line was
vaccinated i.p. by machine at the fresh water farm in February
2009. The vaccine comprised inactivated Aeromonas salmonicida,
Vibrio anguillarum serovar O1 and O2 emulsified in a non-mineral
oil adjuvant (FuruVac 5 Vibrio; Intervet Schering-Plough Animal
Health). On the day of vaccination 50 fish were randomly
collected for visual examination just after passage through the
vaccination machine. First, the fish were checked on the exterior
for needle entries. Second, the abdominal cavity was opened with
a scissor and both cavity and organs were thoroughly examined for
presence of injected vaccine. In case of no vaccine in the abdomen
the fish was checked for incorrect vaccination in the dorsal part. A
year later, the rainbow trout population was transferred to sea
cages. On one day in May 2010 50 trout were randomly taken
from the cages. The individual fish length and weight was
registered and blood samples collected. Finally, the 50 rainbow
Table 1. Descriptive data for 100 commercially farmed rainbow trout.
N fish Length (cm) Weight (g) Condition factor Speilberg score % unvaccinated
Fresh water, February 2009 50 19.561.5 83.4619.6 1.1260.10 – 20
Salt water, May 2010 50 38.763.8 763.16204.7 1.2960.12 1.2560.54 20
Condition factor: CF = (W/L3)6100; where W=weight (g) and L = total length (cm) [18].
Speilberg score is a measure of vaccine-induced side effects.
doi:10.1371/journal.pone.0049672.t001
Table 2. Descriptive data for 50 commercially farmed
rainbow trout divided into unvaccinated and vaccinated
groups.
N fish Length (cm) Weight (g)
Condition
factor
Unvaccinated 10 40.963.2 852.16173.9 1.2460.10
Vaccinated 40 38.263.8 740.96207.7 1.3060.12
Length: P = 0.041, weight: P = 0.12, condition factor: P = 0.12.
Condition factor: CF = (W/L3)6100; where W=weight (g) and L = total length
(cm) [18].
doi:10.1371/journal.pone.0049672.t002
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trout were dissected and thoroughly examined for visible signs of
previous vaccination (fibrinous adhesions, pigmentation/melanin
deposits and/or vaccine residues).
Experimental Vaccine Preparation and Immunisation
48 h culture of the strain V. anguillarum O1 ATCC 43305 was
inactivated with 0.9% formaldehyde for 2 h at room temperature,
washed with PBS, adjusted to an optical density corresponding to
26108 cells/mL PBS, and emulsified with an equal volume of
Freund’s incomplete adjuvant (FIA; Sigma, St. Louis, Mo.). Fish
were immunised by i.p. injections with 0.1 mL of emulsified
vaccine (16107 cells/injection). Immunisations were given three
times with 500 day degree intervals (six weeks).
Bacteria
The strain Vibrio anguillarum O1 6018/1 (ATCC 43305) was
used for immunisations and coating of ELISA plates. Bacteria
were grown with agitation for 48 h at 20uC in veal infusion broth
with 1% NaCl and enumerated as colony forming units (CFU) on
blood agar (blood agar base CM55, Oxoid, supplemented with 5%
bovine blood). Stock cultures were maintained at 280uC in a
broth culture supplemented with 15–20% glycerol.
Serum
Blood was collected as individual samples by caudal venipunc-
ture and serum obtained by allowing the blood to clot overnight at
5uC followed by centrifugation (10.000 rpm for ten minutes
without brakes). Serum samples were stored at 280uC in aliquots
of 0.5 mL. Time points for blood collections from laboratory fish
were one week prior to each immunisation and six weeks after
third and final immunisation.
Field samples were collected likewise. Directly after sampling,
the blood was put on ice and kept cool until arrival at the
laboratory five hours later. At the laboratory blood samples were
placed at 5uC. Serum was isolated the following morning and
stored at 280uC until use.
ELISA for Determination of V. anguillarum O1 Specific
Antibodies
For coating, each well of the microplates (flat-bottom 96-well
plates, MaxiSorpTM, Nunc) was filled with 100 mL coating buffer
(C-3041, Sigma) containing 5 mg/mL of antigen (sonically
disrupted V. anguillarum O1, Artek Sonic Dismembrator, Model
300, 60% for 365 min on ice; protein concentration determined
with BCA Protein Assay, Thermo Scientific) and incubated
overnight at 4uC. For comparison we also tested formalin
inactivated whole-cell V. anguillarum O1 as coating antigen
(5 mg/mL). After removal of coating solution, the wells were
washed three times with 250 mL wash buffer (0.1% Tween 20 in
PBS, pH 7.2) per well. For blocking residual protein binding
capacity, PBS (200 mL) containing 10 g/L bovine serum albumin
(BSA) was added to each well of the microplates, which were then
incubated at room temperature for 1 h. After blocking, the
microplates were washed three times, aspirated, sealed (microplate
seal, Nunc) and stored at 220uC until use.
Serum samples were diluted in assay buffer (0.1% BSA and
0.1% Tween 20 in PBS, pH 7.2) and added to the microplates in
duplicates with 50 mL per well. The microplates were sealed and
placed at 4uC for overnight incubation. The next morning, the
microplates were washed three times and 100 mL of a mouse anti-
salmonid Ig antibody solution (MCA2182, AbD serotec, 1:400
dilution in assay buffer) was added. After 1 h incubation at room
temperature, the microplates were washed three times, and 100 ml
were added to each well of a rabbit F(ab’)2 anti-mouse IgG:HRP
solution (STAR13B, AbD serotech, 1:400 dilution in assay buffer).
Optimal concentrations of the commercial antibodies were
established through chessboard titration experiments (data not
shown). The microplates were left for additional 1 h incubation at
room temperature followed by three washes. Substrate solution
was added (100 ml/well of TMB, Sigma). After 10 min of
incubation, stop solution (100 ml 1N HCL) was added, and the
absorbance at 450 nm was measured with a PowerWave 340
(BioTek).
The limit of detection for the assay was determined as the
concentration corresponding to the signal three standard devia-
tions above the mean for blank wells (sample dilution buffer only).
The linearity of signal as a function of dilution was investigated in
pooled serum samples (n = 20) diluted in sample dilution buffer
ranging from 1:10–1:10000. Intra-assay coefficient of variation
(CV) was determined for eight duplicates of 1:1000 and 1:5000
dilutions of a control serum pool on the same assay plate. The
inter-assay CV was determined for duplicates of 1:1000 and
1:5000 dilutions of the control serum pool on individual plates run
on 14 different days. The stability of the antibodies in the serum
samples was tested when exposed to repeated steps of freeze and
thaw (samples frozen and thawed in the range one to ten times) or
keeping the samples at room temperature for 24 h.
Statistics
The Prism software package (version 4.0 for Macintosh,
GraphPad Software, Inc.) was used to manage data and for
statistical analyses. Mean values and standard deviations were
calculated and differences between means assessed by two-tailed
unpaired t test. Sensitivity and specificity were summarised in a
receiver operating characteristic (ROC) curve and area under the
curve (AUC) given with 95% CI [17]. Moreover, the ROC
analysis was used to identify an optimum cut-off value for the assay
as the point giving the highest possible sensitivity (true-positive
rate) in conjunction with the smallest false-positive fraction. The
significance level was set at 0.05.
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